You are here

  • Home
  • Archive
  • Volume 40, Issue 5
  • The Effects of Perioperative Regional Anesthesia and Analgesia on Cancer Recurrence and Survival After Oncology Surgery: A Systematic Review and Meta-Analysis

Article Text

Article menu

Download PDFPDF

Original articles
The Effects of Perioperative Regional Anesthesia and Analgesia on Cancer Recurrence and Survival After Oncology Surgery: A Systematic Review and Meta-Analysis
  1. Yanxia Sun, MD*,†,
  2. Tianzuo Li, MD‡ and
  3. Tong J. Gan, MD, MHS, FRCA§
  1. From the *Department of Anesthesiology, and †Medical Research Center, BeijingTongRen Hospital, Capital Medical University; and ‡Department of Anesthesiology, Beijing Shijitan Hospital, Capital Medical University, Beijing, China; and §Department of Anesthesiology, Stony Brook University, Stony Brook, NY
  1. Address correspondence to: Tong J. Gan, MD, MHS, FRCA, Department of Anesthesiology, Stony Brook University, Stony Brook, NY (e-mail: tong.gan{at}stonybrookmedicine.edu). Co-corresponding author: Tianzuo Li, MD, Department of Anesthesiology, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China (e-mail: Trmzltz{at}126.com).

Abstract

Background and Objectives Potentially, perioperative regional anesthesia and analgesia (RA) could influence the outcomes of patients with cancer. The aim of this systematic review and meta-analysis was to evaluate the effects of perioperative RA on survival and cancer recurrence after oncologic surgery.

Methods The authors searched computerized databases (from inception to December 2014) and reference lists and considered all studies comparing the effects of RA on cancer recurrence or overall survival with that of general anesthesia (GA). Risk estimates were pooled to determine the effects of RA on risks of cancer recurrence and mortality. Twenty eligible studies were included.

Results Perioperative RA use was associated with improved overall survival (Hazard ratio [HR] = 0.84, 95% CI, 0.75 − 0.94; I 2 =41%), but not with reduced cancer recurrence (HR=0.91, 95% CI, 0.70 − 1.18; I 2=83%).

Conclusions Our meta-analysis suggests that RA may improve overall survival but not reduce cancer recurrence after oncologic surgery.

https://doi.org/10.1097/AAP.0000000000000273

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • The authors declare no conflict of interest.